// App-Quantinova.ai

: Factors associated with physician assessment of severity of asthma or COPD in NOVELTY

Researchers

Presenter

  • Alberto Papi

Principal Investigators

  • Helen K Reddel

  • Alvar Agustí

  • Gary P Anderson

  • Aruna T Bansal

  • Richard Beasley

  • Elisabeth H Bel

  • Christer Janson

  • Barry Make

  • Ian D Pavord

  • David Price

  • Eleni Rapsomaniki

  • Donna K Finch

  • Marianna Alacqua

  • Hana Müllerová

  • Rod Hughes

Medical Centers

  • Respiratory Medicine Unit, Dept of Medical Sciences, Università di Ferrara, Ferrara, Italy

  • Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.

  • Respiratory Institute, Hospital Clinic, University of Barcelona, IDIBAPS, CIBER, Barcelona, Spain,

  • Lung Health Research Centre, Department of Pharmacology and Therapeutics, University of Melbourne, Victoria, Australia

  • Acclarogen Ltd, Cambridge, United Kingdom,

  • Medical Research Institute of New Zealand (MRINZ), Wellington, New Zealand

  • Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

  • Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

  • National Jewish Health and Research and University of Colorado, Denver, United States of America

  • Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  • Observational and Pragmatic Research Institute, Singapore and Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

  • Astra Zeneca, Cambridge, United Kingdom

  • Biopharma R&D, AstraZeneca, Cambridge, United Kingdom

Locations

  • Italy

  • Australia

  • Spain

  • United Kingdom

  • New Zealand

  • Netherlands

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

Disease

  • Asthma

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02760329

Sponsors

  • N/A

Result

  • N/A